FULC (Fulcrum Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Fulcrum Therapeutics, Inc. Common Stock (FULC) is a publicly traded Healthcare sector company. As of May 21, 2026, FULC trades at $6.35 with a market cap of $405.80M and a P/E ratio of -39.05. FULC moved +7.45% today. Year to date, FULC is -41.42%; over the trailing twelve months it is -2.46%. Its 52-week range spans $2.32 to $15.74. Analyst consensus is buy with an average price target of $18.44. Rallies surfaces FULC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns FULC stock?
Hedge funds tracked by Rallies that own FULC include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fulcrum Therapeutics, Inc. Common Stock.
FULC Key Metrics
Key financial metrics for FULC
Metric
Value
Price
$6.35
Market Cap
$405.80M
P/E Ratio
-39.05
EPS
$-0.16
Dividend Yield
0.00%
52-Week High
$15.74
52-Week Low
$2.32
Volume
0
Avg Volume
0
Revenue (TTM)
$80.00M
Net Income
$-9.72M
Gross Margin
0.00%
Top Hedge Funds Holding FULC
Panagora Asset holds 243.56K shares of FULC, changed +148.81% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own FULC include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fulcrum Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for FULC?
Yes. Rallies tracks hedge fund and 13F ownership data for FULC, including fund names, share counts, latest tracked quarter, and position changes when available.
Is FULC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for FULC. It does not provide personalized investment advice.
